Medtronic reports full year and fourth quarter fiscal year 2022 financial results; announces 8% dividend increase
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Bel Fuse acquires dataMate ethernet business for $16 million
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
Medtronic, Inc. (MDT) PT Lowered to $111 at Truist Securities
May 27, 2022 8:09 AM EDTTruist Securities analyst Richard Newitter lowered the price target on Medtronic, Inc. (NYSE: MDT) to $111.00 (from $121.00) while maintaining a Hold rating following earnings.
The analyst commented, "We stay at HOLD following MDT's disappointing F4Q & below CNS F1Q/FY23 guide. We appreciate MDT's... More
Medtronic, Inc. (MDT) PT Lowered to $117 at Cowen; FY23 Can Be a Year of Real Pipeline Progress
May 27, 2022 6:21 AM EDTCowen analyst Joshua Jennings lowered the price target on Medtronic, Inc. (NYSE: MDT) to $117.00 (from $125.00) while maintaining an Outperform rating following earnings. Despite weak guidance, the analyst said FY23 can be a year of real pipeline progress.
The analyst commented, "MDT delivered... More
Medtronic, Inc. (MDT) PT Lowered to $125 at Stifel
May 27, 2022 6:13 AM EDTStifel analyst Rick Wise lowered the price target on Medtronic, Inc. (NYSE: MDT) to $125.00 (from $128.00) while maintaining a Buy rating.
The analyst commented, "Yes. We had hoped that Medtronics F4Q22 (Apr.) would show more visibly-positive signs of CEO Geoff Marthas positive... More
Medtronic (MDT) Misses Q4 EPS by 5c, Offers Guidance
May 26, 2022 6:49 AM EDTMedtronic (NYSE: MDT) reported Q4 EPS of $1.52, $0.05 worse than the analyst estimate of $1.57. Revenue for the quarter came in at $8.09 billion versus the consensus estimate of $8.44 billion.
GUIDANCE:
Medtronic sees FY2023 EPS of $5.53-$5.65, versus the consensus of... More
